Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

More pharmaceutical mergers?

Return to PJ Online Home Page

The Pharmaceutical Journal Vol 264 No 7102p945
June 24, 2000 Business

More pharmaceutical mergers?

Further mergers and acquisitions are likely between major pharmaceutical companies, according to the securities department of German merchant bank Commerzbank.
In a report entitled "Global consolidation", Commerzbank says that the pharmaceuticals market remains fragmented despite a number of recent mergers. Novartis, itself the product of merger between Ciba Geigy and Sandoz, is seen as being the company most likely to make a deal in the near future. Novartis was recently listed on the US stock market. American Home Products is cited as being "the object of its affection". AHP has twice been unsuccessful in completing mergers in the past five years.

Citation: The Pharmaceutical Journal URI: 20001920

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Rate
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.